Calculation
| Debt to equity | = | Total debt, including book overdraft1 | ÷ | Stockholders’ equity1 | |
|---|---|---|---|---|---|
| Dec 31, 2023 | 0.74 | = | 12,009) | ÷ | 16,262) |
| Dec 31, 2022 | 0.75 | = | 11,424) | ÷ | 15,311) |
| Dec 31, 2021 | 0.80 | = | 12,820) | ÷ | 16,080) |
| Dec 31, 2020 | 0.51 | = | 6,980) | ÷ | 13,728) |
| Dec 31, 2019 | 0.49 | = | 5,891) | ÷ | 12,037) |
| Dec 31, 2018 | 0.61 | = | 6,240) | ÷ | 10,161) |
| Dec 31, 2017 | 0.51 | = | 5,061) | ÷ | 9,842) |
| Dec 31, 2016 | 0.40 | = | 4,304) | ÷ | 10,685) |
| Dec 31, 2015 | 0.43 | = | 4,421) | ÷ | 10,346) |
| Dec 31, 2014 | 0.43 | = | 4,159) | ÷ | 9,646) |
| Dec 31, 2013 | 0.32 | = | 3,003) | ÷ | 9,316) |
| Dec 31, 2012 | 0.33 | = | 2,935) | ÷ | 8,847) |
| Dec 31, 2011 | 0.24 | = | 1,965) | ÷ | 8,063) |
| Dec 31, 2010 | 0.30 | = | 2,078) | ÷ | 6,924) |
| Dec 31, 2009 | 0.36 | = | 2,053) | ÷ | 5,776) |
| Dec 31, 2008 | 0.48 | = | 2,162) | ÷ | 4,457) |
| Dec 31, 2007 | 0.49 | = | 1,957) | ÷ | 4,029) |
| Dec 31, 2006 | 0.51 | = | 1,563) | ÷ | 3,054) |
| Dec 31, 2005 | 0.44 | = | 1,095) | ÷ | 2,474) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$ in millions
The financial trajectory from 2005 to 2023 is characterized by a long-term expansion of both total debt and stockholders' equity, with the debt-to-equity ratio experiencing distinct cycles of deleveraging followed by significant leverage increases.
- Initial Deleveraging Phase (2005–2011)
- Between 2005 and 2011, a general downward trend in the debt-to-equity ratio is observed. While total debt rose from 1,095 million to 1,965 million, stockholders' equity grew at a significantly faster rate, increasing from 2,474 million to 8,063 million. This disproportionate growth in equity led the debt-to-equity ratio to decline from 0.44 in 2005 to a period low of 0.24 in 2011.
- Moderate Leverage Expansion (2012–2020)
- From 2012 to 2020, the company entered a period of gradual leverage increase. Total debt climbed from 2,935 million in 2012 to 6,980 million by 2020. Despite steady growth in stockholders' equity, the debt-to-equity ratio trended upward, rising from 0.33 to 0.51, with a notable temporary peak of 0.61 recorded in 2018.
- Acute Debt Increase and Recent Stabilization (2021–2023)
- A significant shift in the capital structure occurred in 2021, marked by a sharp increase in total debt, which jumped from 6,980 million to 12,820 million. This surge pushed the debt-to-equity ratio to its historical maximum of 0.80. In the following two years, the ratio experienced a slight moderation, settling at 0.74 by December 31, 2023. This indicates a sustained higher level of leverage relative to the historical averages maintained between 2005 and 2020.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Comparison to Competitors
| Humana Inc. | Abbott Laboratories | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|
| Dec 31, 2023 | 0.74 | 0.38 | 0.64 | 0.00 | 0.47 | 0.70 |
| Dec 31, 2022 | 0.75 | 0.46 | 0.66 | 0.00 | 0.46 | 0.74 |
| Dec 31, 2021 | 0.80 | 0.50 | 0.64 | 0.00 | 0.51 | 0.64 |
| Dec 31, 2020 | 0.51 | 0.57 | 0.60 | 0.00 | 0.49 | 0.66 |
| Dec 31, 2019 | 0.49 | 0.58 | 0.63 | 0.00 | 0.51 | 0.71 |
| Dec 31, 2018 | 0.61 | 0.64 | 0.67 | 0.00 | 0.51 | 0.71 |
| Dec 31, 2017 | 0.51 | 0.90 | 0.75 | 0.00 | 0.66 | 0.66 |
| Dec 31, 2016 | 0.40 | 1.07 | 0.63 | 0.00 | 0.60 | 0.86 |
| Dec 31, 2015 | 0.43 | 0.42 | 0.69 | 0.00 | 0.68 | 0.95 |
| Dec 31, 2014 | 0.43 | 0.36 | 0.62 | 0.00 | 0.61 | 0.54 |
| Dec 31, 2013 | 0.32 | 0.26 | 0.59 | 0.00 | 0.57 | 0.52 |
| Dec 31, 2012 | 0.33 | 0.77 | 0.63 | 0.00 | 0.62 | 0.54 |
| Dec 31, 2011 | 0.24 | 0.63 | 0.42 | 0.00 | 0.62 | 0.41 |
| Dec 31, 2010 | 0.30 | 0.85 | 0.38 | 0.00 | 0.65 | 0.43 |
| Dec 31, 2009 | 0.36 | 0.72 | 0.34 | 0.00 | 0.57 | 0.47 |
| Dec 31, 2008 | 0.48 | 0.65 | 0.41 | 0.00 | 0.60 | 0.62 |
| Dec 31, 2007 | 0.49 | 0.69 | 0.39 | 0.00 | 0.55 | 0.55 |
| Dec 31, 2006 | 0.51 | 0.88 | 0.29 | 0.00 | 0.84 | 0.36 |
| Dec 31, 2005 | 0.44 | 0.46 | 0.27 | 0.00 | 0.23 | 0.40 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Health Care Equipment & Services)
Humana Inc., debt to equity, long-term trends, comparison to sector (health care equipment & services)
| Humana Inc. | Health Care Equipment & Services | |
|---|---|---|
| Dec 31, 2023 | 0.74 | 0.55 |
| Dec 31, 2022 | 0.75 | 0.57 |
| Dec 31, 2021 | 0.80 | 0.55 |
| Dec 31, 2020 | 0.51 | 0.56 |
| Dec 31, 2019 | 0.49 | 0.58 |
| Dec 31, 2018 | 0.61 | 0.60 |
| Dec 31, 2017 | 0.51 | 0.71 |
| Dec 31, 2016 | 0.40 | 0.72 |
| Dec 31, 2015 | 0.43 | 0.69 |
| Dec 31, 2014 | 0.43 | 0.52 |
| Dec 31, 2013 | 0.32 | 0.47 |
| Dec 31, 2012 | 0.33 | 0.61 |
| Dec 31, 2011 | 0.24 | 0.49 |
| Dec 31, 2010 | 0.30 | 0.55 |
| Dec 31, 2009 | 0.36 | 0.51 |
| Dec 31, 2008 | 0.48 | 0.55 |
| Dec 31, 2007 | 0.49 | 0.53 |
| Dec 31, 2006 | 0.51 | 0.50 |
| Dec 31, 2005 | 0.44 | 0.34 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
| Humana Inc. | Health Care | |
|---|---|---|
| Dec 31, 2023 | 0.74 | 0.82 |
| Dec 31, 2022 | 0.75 | 0.72 |
| Dec 31, 2021 | 0.80 | 0.80 |
| Dec 31, 2020 | 0.51 | 0.92 |
| Dec 31, 2019 | 0.49 | 0.90 |
| Dec 31, 2018 | 0.61 | 0.80 |
| Dec 31, 2017 | 0.51 | 0.82 |
| Dec 31, 2016 | 0.40 | 0.77 |
| Dec 31, 2015 | 0.43 | 0.69 |
| Dec 31, 2014 | 0.43 | 0.54 |
| Dec 31, 2013 | 0.32 | 0.50 |
| Dec 31, 2012 | 0.33 | 0.54 |
| Dec 31, 2011 | 0.24 | 0.47 |
| Dec 31, 2010 | 0.30 | 0.43 |
| Dec 31, 2009 | 0.36 | 0.42 |
| Dec 31, 2008 | 0.48 | 0.42 |
| Dec 31, 2007 | 0.49 | 0.36 |
| Dec 31, 2006 | 0.51 | 0.32 |
| Dec 31, 2005 | 0.44 | 0.30 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).